Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial
- PMID: 25790761
- PMCID: PMC10271001
- DOI: 10.1017/S1368980015000609
Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial
Expression of concern in
-
Calcium plus vitamin D supplementation affects pregnancy outcomes in gestational diabetes: randomized, double-blind, placebo-controlled trial - EXPRESSION OF CONCERN.Public Health Nutr. 2021 Sep;24(13):4369. doi: 10.1017/S1368980021002573. Epub 2021 Jul 23. Public Health Nutr. 2021. PMID: 34296668 Free PMC article. No abstract available.
Abstract
Objective: The present study was designed to assess the effects of Ca+vitamin D supplementation on pregnancy outcomes in women with gestational diabetes mellitus (GDM).
Design: A randomized, double-blind, placebo-controlled trial was conducted among sixty women with GDM. Participants were divided into two groups to receive Ca+vitamin D supplements or placebo. Individuals in the Ca+vitamin D group (n 30) received 1000 mg Ca/d and two pearls containing 1250 µg (50 000 IU) of cholecalciferol (vitamin D(3)) during the intervention (one at study baseline and another at day 21 of the intervention); those in the placebo group (n 30) received two placebos of vitamin D at the mentioned times and placebos of Ca every day for 6 weeks. Pregnancy outcomes were determined.
Setting: A urban community setting in Arak, Iran.
Subjects: Sixty women with GDM and their newborns, living in Arak, Iran were enrolled.
Results: Women treated with Ca+vitamin D had a significant decrease in caesarean section rate (23·3 % v. 63·3 %, P=0·002) and maternal hospitalization (0 v. 13·3 %, P=0·03) compared with those receiving placebo. In addition, newborns of GDM women randomized to Ca+vitamin D had no case of macrosomia, while the prevalence of macrosomia among those randomized to placebo was 13·3 % (P=0·03). Lower rates of hyperbilirubinaemia (20·0 % v. 56·7 %, P=0·03) and hospitalization (20·0 % v. 56·7 %, P=0·03) were also seen in the supplemented group of newborns than in the placebo group.
Conclusions: Ca+vitamin D supplementation for 6 weeks among pregnant women with GDM led to decreased caesarean section rate and maternal hospitalization, and decreased macrosomia, hyperbilirubinaemia and hospitalization in newborns.
Keywords: Calcium; Gestational diabetes mellitus; Pregnancy outcomes; Supplementation; Vitamin D.
Figures
References
-
- Prutsky GJ, Domecq JP, Sundaresh V et al.. (2013) Screening for gestational diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 98, 4311–4318. - PubMed
-
- Karcaaltincaba D, Kandemir O, Yalvac S et al.. (2009) Prevalence of gestational diabetes mellitus and gestational impaired glucose tolerance in pregnant women evaluated by National Diabetes Data Group and Carpenter and Coustan criteria. Int J Gynaecol Obstet 106, 246–249. - PubMed
-
- HAPO Study Cooperative Research Group (2010) Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 117, 575–584. - PubMed
-
- Coustan DR (2014) Diagnosis of gestational diabetes. Scand J Clin Lab Invest Suppl 74, 27–33. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous